WHO ICTRP trial
Study of Safety and Efficacy of Albiglutide in Type 2 Diabetes
CTRI/2009/091/000484 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2009/091/000484 |
|---|---|
| Public title | Study of Safety and Efficacy of Albiglutide in Type 2 Diabetes |
| Scientific title | A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Pioglitazone With or Without Metformin in Subjects with Type 2 Diabetes Mellitus. |
| Primary sponsor | GlaxoSmithKline |
| Secondary sponsors | PPD Pharmaceutical Development India Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India;Argentina;Brazil;China;Czech Republic;France;Germany;Hong Kong;Mexico;Peru;Philippines;Republic of Korea;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States of America |
| Conditions | Health Condition 1: null- Diabetes Mellitus, Type 2 Health Condition 2: E116- Type 2 diabetes mellitus with other specified complications |
| Interventions | Intervention1: Pioglitazone or (metformin Plus pioglitazone) Plus albiglutide (30 mg weekly): 30mg weekly subcutaneous injection Control Intervention1: Pioglitazone or (metformin Plus pioglitazone)Plus albiglutide matching placebo: weekly… |
| Registration date | Jul 21, 2009 |
| Target size | 300 |
| Secondary IDs | 2008-007662-37;GLP112755 - dated 25-November-2008;NCT00849056 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: